These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31477700)

  • 21. Early induction of senescence and immortalization in PGC-1α-deficient mouse embryonic fibroblasts.
    Prieto I; Zambrano A; Laso J; Aranda A; Samper E; Monsalve M
    Free Radic Biol Med; 2019 Jul; 138():23-32. PubMed ID: 31029787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.
    Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ
    Front Immunol; 2019; 10():3023. PubMed ID: 31998307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nucleotide composition of microsatellites impacts both replication fidelity and mismatch repair in human colorectal cells.
    Campregher C; Scharl T; Nemeth M; Honeder C; Jascur T; Boland CR; Gasche C
    Hum Mol Genet; 2010 Jul; 19(13):2648-57. PubMed ID: 20421367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect.
    Campbell MR; Wang Y; Andrew SE; Liu Y
    Oncogene; 2006 Apr; 25(17):2531-6. PubMed ID: 16331258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
    Carethers JM; Pham TT
    In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different in vivo and in vitro transformation of intestinal stem cells in mismatch repair deficiency.
    Keysselt K; Kreutzmann T; Rother K; Kerner C; Krohn K; Przybilla J; Buske P; Löffler-Wirth H; Loeffler M; Galle J; Aust G
    Oncogene; 2017 May; 36(19):2750-2761. PubMed ID: 27941880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3'-UTR poly(T/U) tract deletions and altered expression of EWSR1 are a hallmark of mismatch repair-deficient cancers.
    Kishore S; Piscuoglio S; Kovac MB; Gylling A; Wenzel F; Trapani F; Altermatt HJ; Mele V; Marra G; Peltomäki P; Terracciano L; Zavolan M; Heinimann K
    Cancer Res; 2014 Jan; 74(1):224-34. PubMed ID: 24158095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
    Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T
    Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
    Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
    Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.
    Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK
    Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
    Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
    Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
    McConechy MK; Talhouk A; Li-Chang HH; Leung S; Huntsman DG; Gilks CB; McAlpine JN
    Gynecol Oncol; 2015 May; 137(2):306-10. PubMed ID: 25636458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.
    Biswas S; Trobridge P; Romero-Gallo J; Billheimer D; Myeroff LL; Willson JK; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2008 Feb; 47(2):95-106. PubMed ID: 17985359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azathioprine induction of tumors with microsatellite instability: risk evaluation using a mouse model.
    Bodo S; Svrcek M; Sourrouille I; Cuillières-Dartigues P; Ledent T; Dumont S; Dinard L; Lafitte P; Capel C; Collura A; Buhard O; Wanherdrick K; Chalastanis A; Penard-Lacronique V; Fabiani B; Fléjou JF; Brousse N; Beaugerie L; Duval A; Muleris M
    Oncotarget; 2015 Sep; 6(28):24969-77. PubMed ID: 26327213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
    Honecker F; Wermann H; Mayer F; Gillis AJ; Stoop H; van Gurp RJ; Oechsle K; Steyerberg E; Hartmann JT; Dinjens WN; Oosterhuis JW; Bokemeyer C; Looijenga LH
    J Clin Oncol; 2009 May; 27(13):2129-36. PubMed ID: 19289622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
    Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
    J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When does MMR loss occur during HNPCC progression?
    Shibata D
    Cancer Biomark; 2006; 2(1-2):29-35. PubMed ID: 17192057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol and its Related Polyphenols Contribute to the Maintenance of Genome Stability.
    Matsuno Y; Atsumi Y; Alauddin M; Rana MM; Fujimori H; Hyodo M; Shimizu A; Ikuta T; Tani H; Torigoe H; Nakatsu Y; Tsuzuki T; Komai M; Shirakawa H; Yoshioka KI
    Sci Rep; 2020 Mar; 10(1):5388. PubMed ID: 32214146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA mismatch repair and oligonucleotide end-protection promote base-pair substitution distal from a CRISPR/Cas9-induced DNA break.
    Harmsen T; Klaasen S; van de Vrugt H; Te Riele H
    Nucleic Acids Res; 2018 Apr; 46(6):2945-2955. PubMed ID: 29447381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.